Phase 1 Study of MKC-1 in Patients With Advanced Cancer

This study has been completed.
Sponsor:
Information provided by:
CASI Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00656461
First received: April 7, 2008
Last updated: November 23, 2009
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)